SARS-CoV-2

We began by exploring the difference between eradicating and controlling viruses.

From the onset of the COVID-19 pandemic, researchers have been engaged in forecasting the potential economic and human costs associated with an uncontrolled large-scale pandemic, as well as the corresponding benefits that could be derived from an

Two senior FDA officials, including Dr.

The new booster, available since September, is effective against the currently dominant SARS-CoV-2 variant in the U.S., JN.1.

Armando Simón, a retired psychologist, attempted to rebut an 

I can’t believe we’re having this discussion in September 2023, just as the fall respiratory virus season commences and we're experiencing a new wave of COVID-19, but the politicizers of COVID won’t let up.

The number of deaths from COVID-19 is way down from its peak and pandemic-related restrictions and mandates have virtually disappeared, but there are hints we are in for a late summer surge in infections.

Searching for Who

A recent article in the prestigious New England Journal of Medicine called attention to the urgent need for research and initiatives to address the syndrome known as post-ac

The COVID-19 pandemic has been one of the most devastating events in public health in the U.S. over the last half-century. It’s also the most scrutinized health emergency in history.